BEN
29
-4
OXY
40
-2
AVY
51
-2
HST
32
-3
DUK
80
5
HAS
41
-5
PH
59
-5
COP
45
-3
FIS
67
4
LB
55
-2
SLB
46
-2
PNW
71
2
VZ
57
7
WYNN
34
-3
HRL
41
3
HSIC
56
2
CB
47
-8
ABBV
68
-2
SE
71
-3
NFLX
62
-3
BEN
29
-4
OXY
40
-2
AVY
51
-2
HST
32
-3
DUK
80
5
HAS
41
-5
PH
59
-5
COP
45
-3
FIS
67
4
LB
55
-2
SLB
46
-2
PNW
71
2
VZ
57
7
WYNN
34
-3
HRL
41
3
HSIC
56
2
CB
47
-8
ABBV
68
-2
SE
71
-3
NFLX
62
-3
Financhill
Back

Avidity Biosciences 10K Form

Sell
34

RNA
Avidity Biosciences

Last Price:
$31.78
Seasonality Move:
-10.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RNA News And Ratings

See the #1 stock for the next 7 days that we like better than RNA

RNA Financial Statistics

Sales & Book Value

Annual Sales: $10.9M
Cash Flow: $-103.8M
Price / Cash Flow: 0
Annual Sales: $11.89
Price / Book: 2.71

Profitability

EPS (TTM): -2.89000
Net Income (TTM): $-322.3M
Gross Margin: $8.9M
Return on Equity: -29.4%
Return on Assets: -26.28%

Avidity Biosciences Earnings Forecast

Key Avidity Biosciences Financial Ratios

  • The Gross Profit Margin over the past 1 years for RNA is 100.00%.
  • The Selling, General & Administrative Expenses for RNA have been equal to 791.41% of Gross Profit Margin.
  • The Research & Development expenses have been 2,786.02% of Revenue.
  • The Net Earning history of RNA is -2,957.71% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Avidity Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RNA
CUSIP: 05370A
Website: aviditybiosciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 15.73
Quick Ratio: 15.61

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RNA Technical Analysis vs Fundamental Analysis

Sell
34
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy or a Sell?